×

Stocks Merck & Co Inc

  • Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.

  • Stocks rose for a third straight week as investors got their game on for a recovery. Still, Friday's trading was choppy as investors cheered an early pop from the smaller-than-expected job loss in May but the market couldn't sustain the gains.

  • Stocks struggled to hold gains Friday as investors cheered an early pop from the smaller-than-expected job loss in May but techs and pharmas dragged and the weakeness began to seep into other sectors.

  • Risky Business

    "It's a risky business." I don't think I'll ever forget when a Chief Financial Officer said that at an investor conference last year in lieu of reading the whole boring boilerplate "Safe Harbor Statement."

  • The dollar is rallying, hurting commodities and commodity stocks. Why is the dollar rallying? Better economic news implies higher rates, which makes the dollar more attractive as an investment. A higher dollar means dollar-denominated commodities are more expensive to buy.

  • Stocks shot out of the gate Friday as investors cheered a smaller-than-expected job loss in May.

  • Wall Street is terrified of both inflation and deflation, high and low oil prices, a strong and a weak dollar. Here’s how you avoid the panic.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • How much higher do we need to go before the bears believe this rally is real?

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • asco_new_logo.jpg

    I'm happy to report that I'm scribbling out this blog from the air-conditioned comfort of the convention center in Orlando. It's the first time in my six or seven years of covering ASCO that the organization has let CNBC broadcast live from inside. And, guess what? No one seems freaked out about it.

  • Sliding home prices, more trouble in the Eurozone and another North Korean nuclear bomb test: How will these affect the stock markets? Art Cashin, UBS Financial Services director of floor operations, offered CNBC his insights on Tuesday.

  • Wall Street looks ready to transfer funds from bullish to bearish names, the Mad Money host says.

  • Stocks lost more than 2% Wednesday as bank shares continued to struggle and retail sales unexpectedly fell for a second straight month.

  • graphic_word_ofthe_street.jpg

    A gloomy sales report dragged down investor sentiment on Wednesday sending the S&P 500 to its third straight day of declines.

  • Stocks declined Wednesday as bank shares continued to struggle and retail sales unexpectedly fell for a second straight month. A brief reprieve after the business-inventories report and comments from President Obama fizzled.

  • Novartis Headquarters

    What does it say when a drugmaker hires a Goldman Sachs investment banker as its next Chief Financial Officer? That's the question I'm asking after Novartis announced that it's tapped a managing director of investment banking at Goldman Sachs, Jonathan Symonds, as its CFO apprentice.

  • Stocks pared their losses Wednesday after a report showed business inventories shrunk at a slower pace and remarks from President Obama on health-care reform.  Still, stocks remained under pressure as bank shares continued to struggle and retail sales unexpectedly fell for a second straight month.

  • With stocks rallying for over 2 months now, dividend yields continue to fall back to Earth.  The average dividend yield of the Dow 30 has fallen nearly 30% since the rally began in early March.  See how the 30 companies in the Dow compare.

  • graphic_word_ofthe_street.jpg

    Comments made by Intel CEO Paul Otellini after hours could be bullish for stocks.